- LIM SY, Lee J, Chang E, Kwon JS, et al
Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 : A Randomized Clinical Trial.
Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-04883.
PubMed Abstract available - QASEEM A, Obley AJ, Yost J, Abraham GM, et al
Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults: Living, Rapid Practice Points From the American College of Physicians (Version 3).
Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-25-03766.
PubMed Abstract available - SOMMER I, Dobrescu A, Gadinger A, Sharifan A, et al
Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Review for the American College of Physicians (Version 3).
Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-25-03691.
PubMed Abstract available - MEDEIROS-SILVA J, Zhang Y, Hong M
Phosphatidylinositol Interactions with the SARS-CoV-2 Envelope Protein Investigated by Lipid (13)C Labeling and Solid-State NMR.
Biochemistry. 2026;65:1178-1191.
PubMed Abstract available - COX SN, Bennett JC, Casto AM, Hoffman KL, et al
INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024.
J Infect. 2026 Apr 20:106748. doi: 10.1016/j.jinf.2026.106748.
PubMed Abstract available - ZHANG R, Jian X, Zhang Y, Sun Y, et al
The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.
J Virol. 2026 Apr 21:e0000626. doi: 10.1128/jvi.00006.
PubMed Abstract available - YILDIZ S, El Zahed SS, Villalon-Letelier F, Wang Q, et al
Re-engineering segment 8 facilitates generation of a versatile live-attenuated influenza A virus vector platform for secretory protein delivery.
J Virol. 2026 Apr 21:e0034726. doi: 10.1128/jvi.00347.
PubMed Abstract available - KONG W, Zhang J, Song Y, Song J, et al
Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
J Virol. 2026 Mar 30:e0027026. doi: 10.1128/jvi.00270.
PubMed Abstract available - XIU R, Wang Y, Cai W, Wang Q, et al
Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or M(pro) inhibitors.
J Virol. 2026 Mar 30:e0007626. doi: 10.1128/jvi.00076.
PubMed Abstract available - BRENNAN JW, Wang G, Connor S, Wang X, et al
A respiratory syncytial virus trailer sequence modulates viral replication and the generation and propagation kinetics of copy-back defective viral genomes.
J Virol. 2026;100:e0018426.
PubMed Abstract available - ADAM A, Wu W, Jones MC, Hao H, et al
Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through gammadelta T cell-mediated trained immunity and the activation of SARS-CoV-2-reactive mucosal T cells.
J Virol. 2026 Mar 18:e0165825. doi: 10.1128/jvi.01658.
PubMed Abstract available - BELL JM, Barbre K, Meng L, Lape-Newman B, et al
Influenza Vaccination Coverage Among Nursing Home Residents and Health Care Personnel - United States, 2024-25 Influenza Season.
MMWR Morb Mortal Wkly Rep. 2026;75:195-201.
PubMed Abstract available - BUTLER CC, Pinto AD, Harris V, Holmes J, et al
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.
N Engl J Med. 2026;394:1583-1594.
PubMed Abstract available - SEGEV N, Wilson E, Moehlman M, Corathers SD, et al
Unmasking Adrenal Insufficiency: Adrenal Crisis Triggered by Influenza-Associated Encephalitis.
Pediatrics. 2026 Apr 22:e2025072983. doi: 10.1542/peds.2025-072983.
PubMed Abstract available - LI Y, Nielsen BF, Levin SA, Te Velthuis AJW, et al
Spatio-temporal modelling of in vitro influenza A virus infection: The impact of defective interfering particles on the type I interferon response.
PLoS Comput Biol. 2026;22:e1014198.
PubMed Abstract available - WHITE LA, Leon TM
Forecastability of infectious disease time series: are some seasons and pathogens intrinsically more difficult to forecast?
PLoS Comput Biol. 2026;22:e1014175.
PubMed Abstract available - ORTEGA-MARTIN E, Alvarez-Galvez J
Understanding quality-of-life patterns in long COVID: How Symptoms and socioeconomic conditions shape patient wellbeing.
PLoS One. 2026;21:e0347743.
PubMed Abstract available - CHAVES SS, Castells VB, Mira-Iglesias A, Puig-Barbera J, et al
Rhinovirus/enterovirus contribution to respiratory-associated hospitalizations in adults during respiratory seasons in Spain: A 6-year prospective study.
PLoS One. 2026;21:e0347659.
PubMed Abstract available - LEE J, Bajiya VP, Jung E
Vaccination scenario-based study on seasonal influenza in Republic of Korea.
PLoS One. 2026;21:e0322686.
PubMed Abstract available - PIRZADA P, Wilde A, Doherty GH, Harris-Birtill D, et al
Understanding older adults' perception, acceptance, and adoption of smart home technologies.
PLoS One. 2026;21:e0345563.
PubMed Abstract available - FANG Z, Xu H, Mu Y
Risk-taking responses to crash experience: Evidence from China.
PLoS One. 2026;21:e0347543.
PubMed Abstract available - GARZA J, Sebastian R, Cover B, Sanchez A, et al
Nicotine dependence among critically ill COVID-19 patients: A population-based cohort study.
PLoS One. 2026;21:e0308776.
PubMed Abstract available - MCDONALD C, Grajales AG, Yahia NA, Fisman D, et al
Healthcare resource utilization and cost burden of COVID-19 according to vaccination status in adults in Ontario, Canada, 2021-2023.
PLoS One. 2026;21:e0344690.
PubMed Abstract available - LOVATO N, Appleton SL, Reynolds AC, Gill TK, et al
Relationships between pre-pandemic mental health, sociodemographic factors and health behaviours in older adults during the acute onset of COVID-19 in Australia: A descriptive analysis.
PLoS One. 2026;21:e0346787.
PubMed Abstract available - AUDUREAU E, Jean C, Layese R, Neuraz A, et al
Association between parenthood and survival among 30,386 patients hospitalized with COVID-19.
PLoS One. 2026;21:e0346679.
PubMed Abstract available - IPEKCI AM, Hodel EM, Filsinger M, Wegmuller S, et al
Who would take part in a pandemic preparedness cohort study? The role of vaccine-related affective polarisation: Cross-sectional survey.
PLoS One. 2026;21:e0346420.
PubMed Abstract available - YANG Z, Imouza A, Puelma Touzel M, Amadoro C, et al
Regional and temporal patterns of partisan polarization during the COVID-19 pandemic in the United States and Canada.
PLoS One. 2026;21:e0347327.
PubMed Abstract available - SANDERS CG, Liu M, Fusco JA, Ohl EM, et al
Efficient replication of influenza D virus in the human airway underscores zoonotic potential.
Proc Natl Acad Sci U S A. 2026;123:e2530325123.
PubMed Abstract available - ROBERTSON AH, Wolf AS, Fossum E, Solum G, et al
Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections.
Vaccine. 2026;80:128511.
PubMed Abstract available - DLOUHY P, Petras M, Lesna IK, Macalik R, et al
Transient elevation of NT-proBNP after mRNA COVID-19 vaccination in healthy adults: A longitudinal biomarker analysis.
Vaccine. 2026;80:128535.
PubMed Abstract available - VAN DE BURGWAL LHM, Pronker ES, Herz J
Australia's vaccine legacy: Time for a boost? Mapping an innovation system in a fragmented data environment.
Vaccine. 2026;80:128525.
PubMed Abstract available - WU D, Liu K
Cost and effectiveness of COVID-19 vaccination strategies during the 2023 post-reopening omicron wave in Xinjiang, Western China: Evidence from SIR and Markov models.
Vaccine. 2026;80:128536.
PubMed Abstract available - MAEDA H, Saito N, Igarashi A, Ishida M, et al
Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUS.
Vaccine. 2026;80:128544.
PubMed Abstract available - MORO PL, Romanson B, Marquez P, Zhang B, et al
Adverse events after Pfizer's Respiratory Syncytial Virus Vaccine in pregnant women in the Vaccine Adverse Event Reporting System, 2024-2025, United States.
Vaccine. 2026;80:128547.
PubMed Abstract available - QUINTANAR-SOLARES M, Fleming JA, Musau W, Mulati F, et al
RSV ready? Exploring feasibility and acceptability of RSV immunization options in low- and middle-income countries.
Vaccine. 2026;80:128550.
PubMed Abstract available - KITANO T, Hashimoto E, Sado T, Yoshida S, et al
Maternal effectiveness of respiratory syncytial virus using multicenter healthcare records: A retrospective cohort study.
Vaccine. 2026;80:128566.
PubMed Abstract available - ZHANG L, Lin T, Wang M, Ma X, et al
Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial.
Vaccine. 2026;82:128588.
PubMed Abstract available - FOLEGATTI PM, Pepin S, Tabar C, Fries K, et al
Immunogenicity and safety of recombinant influenza vaccine versus standard inactivated influenza vaccine in children aged 3 to 8 years: results from a phase III randomised study.
Vaccine. 2026;82:128582.
PubMed Abstract available - RICE E, Cheng AC, Britton PN, Carr J, et al
Influenza epidemiology, treatment and prevention in Australian children: Trends from 6 years of PAEDS-FluCAN influenza surveillance (2019-2024).
Vaccine. 2026;82:128592.
PubMed Abstract available
Ann Intern Med
No comments:
Post a Comment